BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neocentromeres
,
Bleomycin
,
rs7903146
,
SLC12A1
,
Response to oxidative stress
,
Liver
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vitexin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CYP1B1
ATF3
CYP1A1
PELI1
NUDT3
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
omega-hydroxylase P450 pathway
MODULE_106
MODULE_6
Cytochrome P450 1B1
MEK_UP.V1_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Fabrication and characterization of nanoemulsions for encapsulation and delivery of vitexin: antioxi…
Preparation of β-CD-Vitexin Microspheres and their Effects on SW480 Cell Proliferation.
Vitexin loaded mixed polymeric micelles: preparation, optimization, evaluation and anti-osteoporotic…
Vitexin ameliorated diabetic nephropathy via suppressing GPX4-mediated ferroptosis.
Absorption, metabolism, and bioactivity of vitexin: recent advances in understanding the efficacy of…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrh…
Open Non-Comparative Study To Evaluate Administration Of a New Nutraceutical
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ